PubMed · 1997 · 79 citations · 19 references
ImmunohematologyProthrombin TimeImmunologyPathologyThrombosisHematologyBleeding DisorderCoagulation TestsLaboratory MedicineAtherosclerosisHealth SciencesRheumatologyAutoimmune DiseaseSystemic Lupus ErythematosusAutoimmunityHypoprothrombinemia-lupus Anticoagulant SyndromeCase ReportThrombopoiesisBlood PlateletLupusHemostasisCoagulopathyMedicineAnticoagulant
A 17-year-old girl was admitted to our department with a hemorrhagic syndrome due to a serious coagulopathy; prothrombin time (PT) INR was 2.46 and the activated partial thromboplastin time (aPTT) ratio 3.46. Coagulation tests with pooled normal fresh plasma did not correct aPTT because of a coagulation inhibitor, and only partially corrected PT. Factor II activity reached only 5%. Diluted Russell viper venom tests (dRVVT) and kaolin clotting time (KCT) of patient plasma (PP) and of a mixture of PP/normal plasma (NP) detected the lupus anticoagulant (LA). The level of factor II antigen was 10%. We diagnosed systemic lupus erythematosus (SLE) with a rare acquired hypoprothrombinemia-LA syndrome (HLAS). The patient was treated with corticosteroids and high-dose Ig and a normal PT value was re-established.
19
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
Munther A. Khamashta, María José Cuadrado, F Mujić et al. · New England Journal of Medicine · 1995 · 1.5K citations · Full text
John T. Brandt, Douglas A. Triplett, Barbara M. Alving et al. · PubMed · 1995 · 1.2K citations
Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Lupus Erythematosus Treatment +11
Guido Finazzi, Vincenzo Brancaccio, Marco Moia et al. · The American Journal of Medicine · 1996 · 435 citations
Antiphospholipid antibodies and venous thromboembolism
JS Ginsberg, PS Wells, P Brill-Edwards et al. · Blood · 1995 · 370 citations · Full text